Novartis AG Statistics
Total Valuation
Novartis AG has a market cap or net worth of $193.93 billion. The enterprise value is $211.34 billion.
Important Dates
The next confirmed earnings date is Friday, January 31, 2025, before market open.
| Earnings Date | Jan 31, 2025 |
| Ex-Dividend Date | Mar 7, 2024 |
Share Statistics
Novartis AG has 2.00 billion shares outstanding. The number of shares has decreased by -2.91% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 2.00B |
| Shares Change (YoY) | -2.91% |
| Shares Change (QoQ) | -0.93% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 1.91B |
Valuation Ratios
The trailing PE ratio is 11.02 and the forward PE ratio is 11.77.
| PE Ratio | 11.02 |
| Forward PE | 11.77 |
| PS Ratio | n/a |
| Forward PS | 3.69 |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 13.14 |
| P/OCF Ratio | 12.14 |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
The stock's EV/EBITDA ratio is 10.07, with an EV/FCF ratio of 14.32.
| EV / Earnings | 12.01 |
| EV / Sales | 4.23 |
| EV / EBITDA | 10.07 |
| EV / EBIT | 11.54 |
| EV / FCF | 14.32 |
Financial Position
The company has a current ratio of 1.11, with a Debt / Equity ratio of 0.74.
| Current Ratio | 1.11 |
| Quick Ratio | 0.78 |
| Debt / Equity | 0.74 |
| Debt / EBITDA | 1.51 |
| Debt / FCF | 2.18 |
| Interest Coverage | 19.33 |
Financial Efficiency
Return on equity (ROE) is 28.79% and return on invested capital (ROIC) is 16.47%.
| Return on Equity (ROE) | 28.79% |
| Return on Assets (ROA) | 10.59% |
| Return on Capital (ROIC) | 16.47% |
| Revenue Per Employee | $656,613 |
| Profits Per Employee | $231,445 |
| Employee Count | 76,057 |
| Asset Turnover | 0.46 |
| Inventory Turnover | 2.09 |
Taxes
In the past 12 months, Novartis AG has paid $975.00 million in taxes.
| Income Tax | 975.00M |
| Effective Tax Rate | 7.66% |
Stock Price Statistics
The stock price has decreased by -1.20% in the last 52 weeks. The beta is 0.51, so Novartis AG's price volatility has been lower than the market average.
| Beta (5Y) | 0.51 |
| 52-Week Price Change | -1.20% |
| 50-Day Moving Average | 106.43 |
| 200-Day Moving Average | 106.41 |
| Relative Strength Index (RSI) | 27.93 |
| Average Volume (20 Days) | 1,120,222 |
Short Selling Information
| Short Interest | 4.49M |
| Short Previous Month | 4.76M |
| Short % of Shares Out | 0.22% |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 3.27 |
Income Statement
In the last 12 months, Novartis AG had revenue of $49.94 billion and earned $17.60 billion in profits. Earnings per share was $8.58.
| Revenue | 49.94B |
| Gross Profit | 37.87B |
| Operating Income | 18.32B |
| Pretax Income | 16.99B |
| Net Income | 17.60B |
| EBITDA | 20.99B |
| EBIT | 18.32B |
| Earnings Per Share (EPS) | $8.58 |
Full Income StatementBalance Sheet
The company has $13.85 billion in cash and $32.16 billion in debt, giving a net cash position of -$18.31 billion or -$9.16 per share.
| Cash & Cash Equivalents | 13.85B |
| Total Debt | 32.16B |
| Net Cash | -18.31B |
| Net Cash Per Share | -$9.16 |
| Equity (Book Value) | 43.44B |
| Book Value Per Share | 21.67 |
| Working Capital | 3.13B |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was $15.97 billion and capital expenditures -$1.21 billion, giving a free cash flow of $14.76 billion.
| Operating Cash Flow | 15.97B |
| Capital Expenditures | -1.21B |
| Free Cash Flow | 14.76B |
| FCF Per Share | $7.38 |
Full Cash Flow StatementMargins
Gross margin is 75.83%, with operating and profit margins of 36.69% and 35.25%.
| Gross Margin | 75.83% |
| Operating Margin | 36.69% |
| Pretax Margin | 25.49% |
| Profit Margin | 35.25% |
| EBITDA Margin | 42.02% |
| EBIT Margin | 36.69% |
| FCF Margin | 29.55% |
Dividends & Yields
This stock pays an annual dividend of $3.78, which amounts to a dividend yield of 3.89%.
| Dividend Per Share | $3.78 |
| Dividend Yield | 3.89% |
| Dividend Growth (YoY) | 8.88% |
| Years of Dividend Growth | 1 |
| Payout Ratio | 44.03% |
| Buyback Yield | 2.91% |
| Shareholder Yield | 6.80% |
| Earnings Yield | 9.08% |
| FCF Yield | 7.61% |
Dividend DetailsAnalyst Forecast
The average price target for Novartis AG is $121.25, which is 24.86% higher than the current price. The consensus rating is "Hold".
| Price Target | $121.25 |
| Price Target Difference | 24.86% |
| Analyst Consensus | Hold |
| Analyst Count | 6 |
| Revenue Growth Forecast (5Y) | 2.95% |
| EPS Growth Forecast (5Y) | 4.58% |
Stock ForecastsStock Splits
The last stock split was on May 11, 2000. It was a forward split with a ratio of 2:1.
| Last Split Date | May 11, 2000 |
| Split Type | Forward |
| Split Ratio | 2:1 |
Scores
Novartis AG has an Altman Z-Score of 3.85 and a Piotroski F-Score of 6.
| Altman Z-Score | 3.85 |
| Piotroski F-Score | 6 |